LSKL is a peptide that is a selective antagonist of thrombospondin-1 (TSP-1), a key activator of latent TGF-β, which is heavily implicated in fibrotic processes like hypertrophic scars and keloids (Xie et al., 2010). This evidence concerns the gene TGFB1 and keloid.